Nitre, Liezel N.
HRN: 23-62-32 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2023
DOXYCYCLINE 100MG (CAP)
10/20/2023
10/27/2023
PO
100mg
BID X 7 Days
Cervical CA; PID
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes